PDK1 and colorectal carcinoma: In summary, HsA suppresses the growth of CRC cells in both in vitro and in vivo models by inhibiting the PDK1 activity, thereby enhancing the metabolic shift from glycolysis to OXPHOS, and consequently inducing mitochondrial ROS-mediated apoptosis.